VERSO BIOSENSE GROUP LIMITED

Active Abingdon

Activities of head offices

0 employees website.com
Life sciences and medical technology Activities of head offices
V

VERSO BIOSENSE GROUP LIMITED

Activities of head offices

Founded 23 Aug 2016 Active Abingdon, United Kingdom 0 employees website.com
Life sciences and medical technology Activities of head offices

Previous Company Names

VIVOPLEX GROUP LIMITED 6 Oct 2017 — 22 Feb 2021
VIVOPLEX MEDICAL LIMITED 23 Aug 2016 — 6 Oct 2017
Accounts Submitted 30 Sept 2025 Next due 30 Sept 2026 4 months remaining
Confirmation Submitted 24 Sept 2025 Next due 5 Sept 2026 4 months remaining
Net assets £8M £249K 2024 year on year
Total assets £11M £1M 2024 year on year
Total Liabilities £3M £2M 2024 year on year
Charges 3
1 outstanding 2 satisfied

Contact & Details

Contact

Registered Address

Milton Park Milton Abingdon Oxfordshire OX14 4RZ United Kingdom

Website

www.example.com

Full company profile for VERSO BIOSENSE GROUP LIMITED (10342970), an active life sciences and medical technology company based in Abingdon, United Kingdom. Incorporated 23 Aug 2016. Activities of head offices. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2017–2024)

Cash in Bank

£165.00

Increased by £102.00 (+162%)

Net Assets

£8.17M

Decreased by £249.27k (-3%)

Total Liabilities

£2.59M

Increased by £1.61M (+164%)

Turnover

N/A

Employees

N/A

Debt Ratio

24%

Increased by 14 (+140%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

1 Allotment 1,667 Shares £100k Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
16 Jun 20231,667£100k£60

Officers

Officers

2 active 1 resigned
Status
Christopher John DicksonDirectorBritishEngland6623 Aug 2016Active
Stephen Edward WithnellDirectorBritishUnited Kingdom453 Apr 2023Active

Shareholders

Shareholders (28)

Charles Edward Dickson
28.2%
Christopher John Dickson
12.0%

Persons with Significant Control

Persons with Significant Control (1)

1 Active 1 Ceased

Charles Edward Dickson

British

Active
Notified 31 Mar 2017
Residence England
DOB February 1982
Nature of Control
  • Ownership Of Shares 25 To 50 Percent,voting Rights 25 To 50 Percent

Davina Margaret Dickson

Ceased 31 Mar 2017

Ceased

Group Structure

Group Structure

VERSO BIOSENSE GROUP LIMITED Current Company
VERSO BIOSENSE LIMITED united kingdom

Charges

Charges

1 outstanding 2 satisfied

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
30 Sept 2025AccountsAnnual accounts made up to 31 Dec 2024
24 Sept 2025Confirmation StatementConfirmation statement made on 22 Aug 2025 with no updates
26 Aug 2025CapitalAllotment of shares (GBP 401,353.5) on 16 Jun 2023
19 May 2025OfficersAppointment of Mrs Kathryn Victoria Rowley as director on 19 May 2025
18 Mar 2025OfficersTermination of Joseph John Cefai as director on 31 Dec 2024
30 Sept 2025 Accounts

Annual accounts made up to 31 Dec 2024

24 Sept 2025 Confirmation Statement

Confirmation statement made on 22 Aug 2025 with no updates

26 Aug 2025 Capital

Allotment of shares (GBP 401,353.5) on 16 Jun 2023

19 May 2025 Officers

Appointment of Mrs Kathryn Victoria Rowley as director on 19 May 2025

18 Mar 2025 Officers

Termination of Joseph John Cefai as director on 31 Dec 2024

Recent Activity

Latest Activity

Annual accounts made up to 31 Dec 2024

7 months ago on 30 Sept 2025

Confirmation statement made on 22 Aug 2025 with no updates

7 months ago on 24 Sept 2025

Allotment of shares (GBP 401,353.5) on 16 Jun 2023

8 months ago on 26 Aug 2025

Appointment of Mrs Kathryn Victoria Rowley as director on 19 May 2025

11 months ago on 19 May 2025

Termination of Joseph John Cefai as director on 31 Dec 2024

1 years ago on 18 Mar 2025